Article Details

Roche's Ocrevus Subcutaneous Gets European Commission Nod By Benzinga

Retrieved on: 2024-06-26 17:25:05

Tags for this article:

Click the tags to see associated articles and topics

Roche's Ocrevus Subcutaneous Gets European Commission Nod By Benzinga. View article details on hiswai:

Excerpt

Roche's shares have lost 1.4% year to date against the industry's growth of 22.1%. Image Source: Zacks Investment Research. Approval of new drugs and ...

Article found on: uk.investing.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up